Skip to main content
Book Chapter

Propentofylline (HWA 285): a Subgroup Analysis of Phase III Clinical Studies in Alzheimer’s Disease and Vascular Dementia

  • Kittner B
Birkhäuser Boston, (1997), 361-365
DOI: 10.1007/978-1-4612-4116-4_54
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Kittner, B. (1997). Propentofylline (HWA 285): a Subgroup Analysis of Phase III Clinical Studies in Alzheimer’s Disease and Vascular Dementia. In Alzheimer Disease (pp. 361–365). Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4116-4_54

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free